Development of CRISPR/dCas9-Effector Systems to Address Fibrosis in Muscle Wasting Disorders

James March

Research output: ThesisDoctoral Thesis

Original languageEnglish
QualificationPh.D.
Awarding Institution
  • Royal Holloway, University of London
Supervisors/Advisors
  • Popplewell, Linda, Supervisor
Thesis sponsors
Award date1 Dec 2021
Publication statusUnpublished - 2021

Keywords

  • Fibrosis
  • Muscle wasting disorders
  • CRISPR/dCas9

Cite this